FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

FDA Funding for Drug Safe Use Research

[ Price : $8.95]

As part of FDAs Safe Use Initiative, CDER director Janet Woodcock announces a funding opportunity for individuals and organization...

FDA Warns Against Vaping THC as Injuries Rise

[ Price : $8.95]

FDA updates a consumer alert to warn against using vaping products containing THC as the latest number of reported cases and death...

DBV Tech BLA for Peanut Allergy Immunotherapy

[ Price : $8.95]

FDA accepts for review a DBV Technologies BLA for its investigational Viaskin peanut immunotherapy for treating peanut-allergic ch...

Trump Claims Pharma Industry Supporting Impeachment

[ Price : $8.95]

President Trump claims that the pharmaceutical industry is secretly plotting the demise of his presidency and supporting the curre...

Clinical Data Standards Pilot: Correction

[ Price : $8.95]

Federal Register notice: FDA corrects a notice that appeared in 8/20 Federal Register announcing a Fit for Use Pilot Program Invit...

AstraZeneca Self-administration Fasenra Approved

[ Price : $8.95]

FDA approves AstraZenecas self-administration version of Fasenra (benralizumab) Pen in a pre-filled, single-use auto-injector as a...

United Health Products PMA for HemoStyp

[ Price : $8.95]

United Health Products files a PMA for HemoStyp, an absorbable hemostatic dressing for use in abdominal, cardiovascular, thoracic ...

Breakthrough Status for Janssens Niraparib

[ Price : $8.95]

FDA grants Janssen Pharmaceutical a breakthrough therapy designation for niraparib, an orally-administered poly ADP-ribose polymer...

Public Citizen Challenges Notion of Drug Prices Falling

[ Price : $8.95]

Public Citizen challenges President Trumps assertion that his actions are responsible for lower drug prices.

Guide on Enzyme Replacement Therapy Products

[ Price : $8.95]

Federal Register notice: FDA makes available a final guidance entitled Investigational Enzyme Replacement Therapy Products: Noncli...